ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.254,18
1,03%
S&P 500
5.473,50
-0,25%
Dow Jones
39.005,03
0,44%
Euro vs US Dollar
1,07076
-0,37%
Bitcoin
64.806,58
-0,25%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. TELA Bio Inc (TELA)

  7. TELA Bio Inc (TELA) News

TELA TELA Bio Inc

5,09
0,01 (0,20%)
Zuletzt aktualisiert: 18:29:09
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
TELA Bio Inc TELA NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
0,01 0,20% 5,09 18:29:09
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
5,10 5,05 5,235 5,08
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
10.6.202415:00EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
06.6.202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.6.202422:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.6.202422:55EDGAR2Form 3 - Initial statement of beneficial ownership of..
06.6.202422:15EDGAR2Form 8-K - Current report
04.6.202422:05GLOBETELA Bio Appoints Jeffrey Blizard to its Board of Directors
20.5.202422:15EDGAR2Form 8-K - Current report
20.5.202422:03GLOBETELA Bio Appoints Greg Firestone as Chief Commercial Officer
10.5.202422:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10.5.202422:05GLOBETELA Bio Announces Inducement Grants Under Nasdaq Listing..
09.5.202422:20EDGAR2Form 8-K - Current report
09.5.202422:05GLOBETELA Bio Reports First Quarter 2024 Financial Results
25.4.202413:00GLOBETELA Bio to Announce First Quarter 2024 Financial Results
15.4.202413:00GLOBETELA Bio Announces U.S. Commercial Launch of..
08.4.202413:00GLOBETELA Bio Welcomes Acclaimed Surgeon as Vice President of..
21.3.202421:05GLOBETELA Bio Achieves Record Fourth Quarter and Full Year 2023..
21.3.202412:00GLOBETELA Bio Announces U.S. Commercial Launch of LIQUIFIX™ – the..
20.3.202412:00GLOBETELA Bio Announces Sale of Distribution Rights for Wound..
29.2.202413:00GLOBETELA Bio to Announce Fourth Quarter and Full Year 2023..
27.2.202422:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.2.202422:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.2.202422:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.2.202422:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.2.202422:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.2.202422:05GLOBETELA Bio Announces Inducement Grants Under Nasdaq Listing..
16.2.202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.2.202422:05EDGAR2Form 3/A - Initial statement of beneficial ownership of..
14.2.202423:23EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14.2.202412:35EDGAR2Form SC 13G - Statement of acquisition of beneficial..
19.1.202422:05GLOBETELA Bio Announces Inducement Grants Under Nasdaq Listing..
15.12.202322:05GLOBETELA Bio Announces Inducement Grants Under Nasdaq Listing..
07.12.202322:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.12.202313:00GLOBETELA Bio to Take Part in Connecting the Dots
16.11.202313:00GLOBETELA Bio to Participate in Piper Sandler’s 35th Annual..
15.11.202302:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.11.202322:44EDGAR2Form S-3 - Registration statement under Securities Act of..
13.11.202322:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10.11.202322:05GLOBETELA Bio Announces Inducement Grants Under Nasdaq Listing..
09.11.202322:05GLOBETELA Bio Reports Third Quarter 2023 Financial Results
26.10.202313:00GLOBETELA Bio to Announce Third Quarter 2023 Financial Results
20.10.202322:06EDGAR2Form 8-K - Current report
06.10.202317:47EDGAR2Form SC 13G - Statement of acquisition of beneficial..
28.9.202322:05EDGAR2Form 8-K - Current report
18.9.202322:05GLOBETELA Bio to Participate in the Gilmartin Group Emerging..
16.8.202313:15EDGAR2Form 8-K - Current report
16.8.202313:00GLOBETELA Bio Announces U.S. Commercial Launch of OviTex® PRS..
10.8.202322:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09.8.202322:05EDGAR2Form 8-K - Current report
09.8.202322:03GLOBETELA Bio Reports Second Quarter 2023 Financial Results
04.8.202322:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Kürzlich von Ihnen besucht

NASDAQ
TELA
TELA Bio
BOV
C2GN34
Cognex
AQSE
GMR.GB
Gaming Realms
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten